CREB3L1 and prostate adenocarcinoma: The results revealed that significantly higher CREB3L1 expression was observed in 7 cancer types than their corresponding adjacent non-cancerous tissues, including breast invasive carcinoma (BRCA), cholangiocarcinoma (CHOL), kidney chromophobe (KICH), liver hepatocellular carcinoma (LIHC), pancreatic adenocarcinoma (PAAD), prostate adenocarcinoma (PRAD) and stomach adenocarcinoma (STAD).